Yes, you can wear contacts, but it is advisable to remove them before instilling the drop and wait at least 15 minutes before reinserting to avoid drug residue on the lens surface.
Prolonged use can cause irreversible darkening of the iris, especially in people with light-coloured eyes. The change usually stabilises after several months of continuous therapy.
Bimatoprost is not recommended during pregnancy unless the potential benefit outweighs the risk. Discuss any plans for pregnancy with your ophthalmologist before starting treatment.
A single 0.01 % drop contains about 0.05 ml. At one drop per eye per day, a 3 ml bottle provides roughly 30 days of therapy for bilateral use.
Severe pain may indicate an adverse reaction such as inflammation or ocular hypotony. Seek urgent ophthalmic assessment; do not continue the medication until cleared by a clinician.
Combination therapy (e.g., with a beta-blocker or carbonic anhydrase inhibitor) is common and often effective. Your eye-care professional will tailor the regimen and monitor IOP closely.
Conjunctival hyperemia (redness) is a frequent, dose-related side effect caused by vasodilation of ocular blood vessels. It is usually mild and may lessen with continued use.
Systemic absorption is minimal, but trace amounts can enter the bloodstream. Report any unexpected systemic symptoms (e.g., headaches, respiratory changes) to your doctor.
Return the empty container to a pharmacy for safe disposal or follow local NHS guidance for pharmaceutical waste. Do not discard it in household recycling bins.
Careprost + Applicators is a branded ophthalmic preparation that contains bimatoprost as its active ingredient. It is supplied in a 3 ml bottle together with a sterile applicator (dropper) for direct instillation into the eye.
The product’s formulation is a sterile aqueous solution intended for topical ocular use.
Bimatoprost belongs to the prostaglandin-analogue family. After a drop is placed on the eye’s surface, the drug penetrates the cornea and reaches the trabecular meshwork, the primary drainage pathway for aqueous humour.
By improving fluid drainage, the medication helps protect the optic nerve from pressure-related damage.
Approved indications (UK, MHRA)
These indications are based on clinical trial evidence showing that bimatoprost effectively reduces IOP compared with placebo and other prostaglandin analogues.
Bimatoprost is also employed off-label for enhancement of eyelash growth. This use mirrors the formulation marketed elsewhere as Latisse® (the same active ingredient at the same concentration).
Patients with systemic conditions such as uncontrolled asthma or cardiovascular disease are not automatically excluded, but clinicians should assess individual risk.
These effects generally diminish with continued use or after adjusting the drop technique.
If you experience sudden eye pain, vision loss, or severe redness, seek urgent medical attention.
Patients should disclose all ocular and systemic medications, including over-the-counter preparations and herbal supplements, to their prescriber.
Missed dose: If you remember the missed dose within a few hours, you may administer it. Skip it if it is close to the next scheduled dose; do not double-dose.
Overdose: Symptoms may include excessive eye redness, severe ocular pain, or blurred vision. Seek urgent medical care; treatment is supportive.
Discontinuation: Do not stop abruptly without consulting your eye-care professional. A gradual taper is unnecessary for bimatoprost, but monitoring of IOP after cessation is essential to detect rebound pressure rise.
Regular follow-up ensures that the target IOP is achieved and that any adverse effects are identified early.
This article provides educational information about Careprost + Applicators and is not a substitute for professional medical advice. Treatment decisions, including the use of medicines for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
